Home / Our team / Dr Annet Nakaganda
Leadership
Dr Annet Nakaganda
Founder · Director of Research, Innovation & Education
Also on the team as Clinical officer & cancer epidemiologist (Our researchers)
Dr. Annet is a cancer epidemiologist who created and established the organisation. She conceived the idea, developed the vision and mission, and brought ACCR into existence to fight cancer through research and the law.
She leads and manages research and innovation by developing and implementing a strategic research plan aligned with the organisation's goals, identifying and securing funding for research projects, including grants, contracts, partnerships and internal budgets, and managing the team of researchers, scientists and innovators.
She oversees the planning, execution and completion of research projects and ensures that research and innovation meet high quality standards and adhere to ethical guidelines and regulatory requirements. She also advocates for policies and regulations that support research and innovation.
An expert in clinical trials and epidemiological research for cancer control, with a Ph.D. in medicine, a Master's in Public Health (with Distinction) from the University of Manchester and a BSc in Psychology from Makerere University.
Dr. Nakaganda has been involved in clinical research for over 20 years, as principal investigator, research clinician, and in research coordination, governance, monitoring and auditing. Her career began in the early 2000s with clinical trials on prevention of mother-to-child transmission of HIV, including the seminal HIVNET 012 trial, which led to the widespread adoption of single-dose Nevirapine, an effective, low-cost strategy at the time.
She later moved into cancer research, helping to establish the Uganda Cancer Institute's Research and Training Directorate and its Cancer Epidemiology and Clinical Trials Unit. She has worked to build the Uganda National Cancer Control Programme and led the harmonisation of East African cancer registration guidelines and procedures. Internationally, she has worked at the NHS Manchester Royal Infirmary on COVID-19 trials and haemato-oncology clinical trials, including CAR T-cell therapy trials.
She began teaching in 2016 as a Teaching Associate on the University of Manchester's Master of Public Health programme and its BSc Biomedical Science course, and supported the design of Manchester's BSc in Public Health. She is a subject matter expert and lecturer on the MSc Clinical Research and MSc Public Health and Health Promotion curricula at iHeed–University of Warwick. She teaches Research Ethics and Good Clinical Practice and has taught over 600 researchers through around 50 in-country trainings. She has received numerous accolades and is published in peer-reviewed international journals and conferences.
Her current work focuses on expanding best practices for cancer research and control, and on novel approaches to getting locally generated evidence used sooner to direct cancer control in low-resource settings. Her specialties include:




